Internal Server Error

My Health - About the company

My Health is an unfunded company based in Hasselt (Belgium), founded in 2017. It operates as a Developer of microbial probiotic strains. My Health has not raised any funding yet. The company has 76 active competitors, including 18 funded and 13 that have exited. Its top competitors include companies like Novozymes, Seres Therapeutics and Infinant Health.

Company Details

Developer of microbial probiotic strains. The company focuses on the development of microbiome solutions for functional dyspepsia with DUOSPORE, and have launched a diverse portfolio to support people with various needs.
Key Metrics
Founded Year
2017
Location
Hasselt, Belgium
Stage
Unfunded
Ranked
Employee Count
13 as on May 31, 2026
Similar Companies
Sign up to download My Health's company profile

My Health's funding and investors

My Health has not raised any funding rounds yet.

My Health's founders and board of directors

Founder? Claim Profile

My Health's employee count trend

My Health has 13 employees as of May 26. Here is My Health's employee count trend over the years:
Employee count trend for My Health
lockUncover My Health's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

My Health's Competitors and alternates

Top competitors of My Health include Novozymes, Seres Therapeutics and Infinant Health. Here is the list of Top 10 competitors of My Health, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Novozymes
Novozymes
2000, Bagsvaerd (Denmark), Acquired
Developer of biosolutions and enzymes for multiple industries and applications of biotechnology
$9.75M
73/100
2nd
Logo for Seres Therapeutics
Seres Therapeutics
2010, Cambridge (United States), Public
Developer of microbiome therapeutics to treat a wide range of diseases
$134M
60/100
3rd
Logo for Infinant Health
Infinant Health
2011, Norwalk (United States), Series C
Microbiome-based products to improve infant immune system
$39.2M
59/100
4th
Logo for Biocodex
Biocodex
1953, Gentilly (France), Unfunded
Manufactures a range of health supplements and pharmaceuticals
-
-
59/100
5th
Logo for Genome & Company
Genome & Company
2015, Seongnam-si (South Korea), Public
Developer of microbiome-based immuno-oncology drugs
-
55/100
6th
Logo for Resbiotic
Resbiotic
2021, Birmingham (United States), Series A
Provider of probiotic supplements to improve health
$20.6M
55/100
7th
Logo for Nextbiotix
Nextbiotix
2016, Dijon (France), Series A
Developer of probiotic for the treatment of inflammatory bowel diseases
$30.4M
54/100
8th
Logo for Oragenics
Oragenics
1996, Tampa (United States), Public
Developer of novel treatments for infectious diseases and oral mucositis as well as probiotics for oral health
-
53/100
9th
Logo for AMILI
AMILI
2019, Singapore (Singapore), Series A
Provider of gut microbiome data insights, analytics, tests, and therapeutics
$10.5M
52/100
10th
Logo for Rebiotix
Rebiotix
2011, Roseville (United States), Acquired
Developing microbiota restoration therapy for the treatment of infectious diseases.
$29.3M
51/100
49th
Logo for My Health
My Health
2017, Hasselt (Belgium), Unfunded
Developer of microbial probiotic strains
-
-
26/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on My Health's competitors? Click here to see the top ones

My Health's Investments and acquisitions

My Health has made no investments or acquisitions yet.

Reports related to My Health

Here is the latest report on My Health's sector:

News related to My Health

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about My Health

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford